Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 706 participants.

Also called NCT01927549

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 706 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01927549
Other papers using this trial's data
  • Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial JAMA cardiology, 2020-12-01 DOI, PubMed 32845312, PMC7450400 Not in the PMC Open Access subset.
  • Culprit lesion location and outcomes in patients with multivessel disease and infarct-related cardiogenic shock: a core laboratory analysis of the CULPRIT-SHOCK trial EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2021-08-06 DOI, PubMed 32894227, PMC9725066 Not in the PMC Open Access subset.
  • Effects of ON-Hours Versus OFF-Hours Admission on Outcome in Patients With Myocardial Infarction and Cardiogenic Shock: Results From the CULPRIT-SHOCK Trial Circulation. Cardiovascular interventions, 2020-09 DOI, PubMed 32883104
  • Influence of Culprit Lesion Intervention on Outcomes in Infarct-Related Cardiogenic Shock With Cardiac Arrest Journal of the American College of Cardiology, 2023-03-28 DOI, PubMed 36948733
  • Mild induced hypothermia in patients with infarct-related cardiogenic shock and cardiac arrest: insights from the CULPRIT-SHOCK trial European heart journal. Acute cardiovascular care, 2026-03-10 DOI, PubMed 40986817
  • One-Year Outcomes after PCI Strategies in Cardiogenic Shock The New England journal of medicine, 2018-11-01 DOI, PubMed 30145971
  • PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock The New England journal of medicine, 2017-12-21 DOI, PubMed 29083953
  • Plasma Proteome Analysis Identifies Vascular Endothelial Growth Factor Receptor 1 as a Prognostic Biomarker in Cardiogenic Shock Circulation. Heart failure, 2025-12 DOI, PubMed 41031405
  • Sex-Specific Management in Patients With Acute Myocardial Infarction and Cardiogenic Shock: A Substudy of the CULPRIT-SHOCK Trial Circulation. Cardiovascular interventions, 2020-03 DOI, PubMed 32151161

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01927549. Randomized; no masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2017-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock
Acronym
CULPRIT-SHOCK
Condition
Cardiogenic Shock
Condition
Acute Myocardial Infarction
Condition
Complications
Intervention (Procedure)
Immediate multivessel PCI (percutaneous coronary intervention)
Intervention (Procedure)
Culprit Lesion only PCI
Lead sponsor
University of Luebeck (class: other)
Collaborator
European Commission (class: other)
Collaborator
German Cardiac Society (class: other)
Collaborator
Deutsche Stiftung für Herzforschung (class: other)
Collaborator
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (class: other)

Record details

Record id
cardio:ct-nct01927549
Content hash
120653e4ee09a90a9ff004f4a7c97fd414f668bedd53241ef141dc44edd53b59